drugset / Trial / NCT05222412

Managed Access Programs for LNP023, Iptacopan

NCT05222412

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration form is to list all Managed Access Programs (MAPs) related to LNP023, Iptacopan

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Iptacopan Small molecule